cagrisema cagrilintide semaglutide phase 3 obesity in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 2.4 mg + 2.4 mg once weekly • 📉 –20.4% weight loss (non-diabetic) & –13.7% (T2D) Cagrilintide: Weekly Amylin Analog —

These arrangements tie payments to patient outcomes weight loss benchmarks or reduced hospitalizationsrather than simply paying per prescription

Both Wegovy and Ozempic contain the GLP-1 agonist semaglutide, but Wegovy is prescribed for long-term weight management and certain forms of liver disease, while Ozempic is used to control blood sugar in type 2 diabetes and help protect the heart and kidneys

While there is evidence of a reduction in cardiovascular risk in diabetic patients treated with semaglutide, the long-term effects in subjects with other comorbidities must be clarified

For them, semaglutide is strictly a drug for losing pounds

Sharps disposal